A highly immunogenic putative Mycobacterium kansasii lipoprotein

References

1. Andersen P. 1994; Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins.. Infect Immun 62:2536–2544
   [Google Scholar]
2. Bordier C. 1981; Phase separation of integral membrane proteins in Triton X-114 solution.. J Biol Chem 256:1604–1607
   [Google Scholar]
3. Colditz G.A., Brewer T.F., Berkey C.S., Wilson M.E., Burdick E., Fineberg H.V., Mosteller F. 1994; Efficacy of BCG vaccine in the prevention of tuberculosis - meta analysis of the published literature.. J Am Med Assoc 271:698–702
   [Google Scholar]
4. Collins M.E., Patki A., Wall S., Nolan A., Goodger J., Woodward M.J., Dale J.W. 1990; Cloning and characterization of the gene for the ‘19 kDa’ antigen of Mycobacterium bovis. . J Gen Microbiol 136:1429–1436
   [Google Scholar]
5. Davies P.O.D. 1994; Infection with Mycobacterium kansasii. . Thorax 49:435–436
   [Google Scholar]
6. Devereux J., Haerberli P., Smithies O. 1984; A comprehensive set of sequence analyses programs for the VAX.. Nucleic Acids Res 12:387–395
   [Google Scholar]
7. Dooley S.D., Jarvis W.R., Martone W.J., Snider D.E. 1992; Multidrug-resistant tuberculosis.. Ann Intern Med 117:257–259
   [Google Scholar]
8. Estrada I., Guitterez M., Esparza J., Quesada-Pascual F., Estrada-Parra S., Passani L. 1992; Use of synthetic peptides corresponding to sequences of Mycobacterium leprae to study delayed- type hypersensitivity responses in sensitized guinea pigs.. Int J Lepr 60:18–27
   [Google Scholar]
9. Fikrig E., Barthold S.W., Marcantonio N., Deponte K., Kantor F. S., Flaveil R. 1992; Roles of ospA, ospB, and flagellin in protective immunity to Lyme borreliosis in laboratory mice.. Infect Immun 60:657–661
   [Google Scholar]
10. Fine P.E.M., Rodrigues L.C. 1990; Modern vaccines - mycobacterial diseases.. Lancet 335:1016–1020
    [Google Scholar]
11. Finke M., Duchene M., Eckhardt A., Domdey H., Von Specht B.U. 1990; Protection against experimental Pseudomonas aeruginosa infection by recombinant P. aeruginosa lipoprotein I expressed in Escherichia coli. . Infect Immun 58:2241–2244
    [Google Scholar]
12. Gelber R.H., Mehra V., Bloom B., Murray L.P., Sui P., Tsang M. 1994; Vaccination with pure Mycobacterium leprae inhibits M. leprae multiplication in mouse footpads.. Infect Immun 62:4250–4255
    [Google Scholar]
13. Green B.A., Quinn-Dey T., Zlotnik G.W. 1987; Biologic activities of antibody to a peptidoglycan-associated lipoprotein of Haemophilus influenzae against multiple clinical isolates of H. influenzae type b.. Infect Immun 55:2878–2883
    [Google Scholar]
14. Horsburgh C.R., Selik R. 1989; The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS).. Am Rev Respir Dis 139:4–7
    [Google Scholar]
15. Horwitz M.A., Lee B.W.E., Dillon B.J., Harth G. 1995; Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. . Proc Natl Acad Sci, USA 921530–1534
    [Google Scholar]
16. Kohler G., Milstein C. 1975; Continuous culture of fused cells secreting antibody of predetermined specificity.. Nature 256:495–497
    [Google Scholar]
17. Levine B., Chaisson R.E. 1991; Mycobacterium kansasii-. a cause of treatable pulmonary disease associated with advanced human immunodeficiency virus (HIV) infection.. Ann Intern Med 114:861–868
    [Google Scholar]
18. Lillo M., Orengo P., Cernoch P., Harris R.L. 1990; Pulmonary and disseminated infection due to Mycobacterium kansasii - a decade of experience.. Rev Infect Dis 12:760–767
    [Google Scholar]
19. Mackall J.G, Bai G.H., Rouse D.A., Armoa G., Chuidian F., Nair J., Morris S.L. 1993; A comparison of the T cell delayed- type hypersensitivity epitopes of the 19 kD antigens from Mycobacterium tuberculosis and Mycobacterium intracellulare using synthetic peptides.. Clin Exp Immunol 93:172–177
    [Google Scholar]
20. Morris S.L., Rouse D.A., Hussong D., Chaparas S.D. 1988; Isolation and characterization of a recombinant λgtl 1 bacteriophage which expresses an immunoreactive Mycobacterium intracellulare protein in Escherichia coli. . Infect Immun 56:3026–3031
    [Google Scholar]
21. Morris S.L., Rouse D.A., Hussong D., Chaparas S.D. 1990; Isolation and characterization of recombinant λgtll bacteriophages expressing four different Mycobacterium intracellulare antigens.. Infect Immun 58:17–20
    [Google Scholar]
22. Morris S.L., Bermudez L., Chaparas S.D. 1991; Mycobacterium avium complex disease in patients with AIDS: seroreactivity to native and recombinant mycobacterial antigens.. J Clin Microbiol 29:2715–2719
    [Google Scholar]
23. Morris S.L, Nair J., Rouse D.A. 1992; The catalase-peroxidase of Mycobacterium intracellulare-, nucleotide sequence analysis and expression in Escherichia coli. . J Gen Microbiol 138:2363–2370
    [Google Scholar]
24. Nair J., Rouse D.A., Morris S.L. 1992; Nucleotide sequence analysis and serologic characterization of the Mycobacterium intracellulre homologue of the Mycobacterium tuberculosis 19 kDa antigen.. Mol Microbiol 6:1431–1439
    [Google Scholar]
25. Nair J., Rouse D.A., Morris S.L. 1993; Nucleotide sequence analysis and serologic characterization of a 27 kilodalton Myco-bacterium intracellulare lipoprotein.. Infect Immun 61:1074–1081
    [Google Scholar]
26. Reilly L.W. 1993; Drug resistant tuberculosis.. Clin Infect Dis 17: suppl 2 S442–S446
    [Google Scholar]
27. Rouse D.A., Morris S.L., Karpas A., Probst P.G., Chaparas S.D. 1990; Production, characterization, and species specificity of monoclonal antibodies to Mycobacterium avium complex protein antigens.. Infect Immun 58:1445–1449
    [Google Scholar]
28. Shafer R.W., Sierra M.F. 1992; Mycobacterium xenopi, Mycobacterium fortuitum, Mycobacterium kansasii and other non-tuberculous mycobacteria in an area of endemicity for AIDS.. Clin Infect Dis 15:161–162
    [Google Scholar]
29. Sheerer R., Sable R., Sonnenberg M., Cooper S., Spenser B., Schevimmer S., Kucha F., Muthuswamy P., Kallech C. 1986; Disseminated infection with Mycobacterium kansasii in the acquired immunodeficiency syndrome.. Ann Intern Med 105:710–712
    [Google Scholar]
30. Shinnick T.M., Plikaytis B.B., Hyche A.D., Van Landinham R.M., Walker L.L. 1989; The Mycobacterium tuberculosis BCG A protein has homology with the Escherichia coli groES protein.. Nucleic Acids Res 17:1254
    [Google Scholar]
31. Stover C.K., Bansal G.P., Hanson M.S., Burlein J.E., Palaszynski S.R., Young J.F., Koenig S., Young D.B., Sadziene A., Barbour A.G. 1993; Protective immunity elicited by recombinant Bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine.. J Exp Med 178:197–209
    [Google Scholar]
32. Studier F.W., Moffat B.W. 1986; Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes.. J Mol Biol 189:113–130
    [Google Scholar]
33. Vordermeier H.M., Harris D.P., Mehrota P.K., Roman E., Elsaghier A., Ivanyi J. 1992; M. tuberculosis complex specific T- cell stimulation and DTH reactions induced with a peptide from the 38 kDa protein.. Scand J Immunol 35:711–718
    [Google Scholar]
34. Wallace R.J., O’Brien R., Glassroth J., Raleigh J., Dutt A. 1990; Diagnosis and treatment of disease caused by nontuberculous mycobacteria.. Am Rev Respir Dis 142:940–953
    [Google Scholar]
35. Wu H.C., Tokunaga M. 1986; Biogenesis of lipoproteins in bacteria.. Curr Top Microbiol Immunol 125:127–157
    [Google Scholar]
36. Young D.B., Garbe T.R. 1991; Lipoprotein antigens of Mycobacterium tuberculosis. . Res Microbiol 142:55–65
    [Google Scholar]
37. Young L.S., Inderlied C.B., Berlin O.G., Gottlieb M.S. 1986; Mycobacterial infections in AIDS patients with an emphasis on the Mycobacterium avium complex.. Rev Infect Dis 8:1024–1033
    [Google Scholar]